AVAC calls on donors.

AIDS vaccine study is a critical part of that revolution and upon this full day AVAC phone calls on donors, policy makers and others to strengthen support for AIDS vaccine research. This is a thrilling time in HIV avoidance research. In the last season we’ve seen positive results from three trials that present the promise of antiretroviral medicines to prevent in addition to treat HIV, said Mitchell Warren, AVAC executive director. Simultaneously, it is necessary that the improvement in the search for an AIDS vaccine not really be over-looked. Global plans, funding advocacy and agendas strategies for HIV must consist of HIV vaccine research. We know that truly effective avoidance incorporates a broad range of different tools and strategies and that, historically, vaccines have already been the most powerful epidemic-ending tools ever deployed.The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free of charge assistance of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Panel Kaiser and Company Family members Foundation. All rights reserved.

AIDS medical textbook designed specifically for sufferers and doctors in resource-poor regions Warner C. Greene, MD, who directs immunology and virology analysis at the Gladstone Institutes, has joined with additional global AIDS experts release a a locally affordable edition of the world’s leading Helps medical textbook. That today are hardest hit by the disease Designed designed for regions, this new text may be the most recent weapon in an evergrowing arsenal targeted at curbing the spread of HIV/AIDS world-wide.